Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder

ConditionSpina Bifida
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-18
SponsorUniversity of Texas Southwestern Medical Center

About this trial

The purpose of this research study is to determine the effectiveness of a treatment called "transcutaneous tibial nerve stimulation" or "TTNS" in the treatment of urinary leakage for patients with spina bifida. This treatment involves electrical stimulation of a nerve by the ankle. Participants will complete urodynamic testing and questionnaires prior to the treatments. Participants will then complete 6 weekly treatments of TTNS. Participants will learn how to do the treatment in the clinic, and then can complete the treatments at home. For patients with a good response, the treatments may be continued for another 6 weeks, for a total of 6 weeks.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 8-18

Patient at TSRH

Diagnosis of lumbosacral spina bifida (myelomeningocele, meningocele, lipoma of spinal cord, myelocystocele, diastematomyelia, fatty/thickened filum)

Incontinence refractory to compliant catheterization (compliance with catheterization as assessed by their treating provider)

Disqualifiers

Ages <8 or >18

Diagnosis not listed above

Patients that have received reconstructive surgeries (i.e. augmentation or bladder neck sling) with the exception for a single APV

Patient received Botox treatment within 1 year of enrollment

Trial design

Design model

Single group

Treatments tested in this trial

  • Transcutaneous Tibial Nerve Stimulation (TTNS) treatment

    Device

    Spina Bifida pediatric patients with neurogenic bladder will be in Transcutaneous Tibial Nerve Stimulation (TTNS) treatment. Patient will complete 6 weeks of 30 minute treatment sessions (these can be done at home after the first teaching session)

Treatment groups

12 Participants
are divided into 1 treatment group
Group A: TTNS Treatment ArmExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of leakage episodes

Number of leakage episodes will be measured by 3 Day Bladder Diary

Time frame
12 weeks

Secondary outcomes

1

Leak weight

Leak weight of the diapers will be measured by wet-diaper weight in grams

Time frame
12 weeks
2

Number of pads used

Number of pads used will be measured using 3-day bladder diary

Time frame
12 weeks
3

Number of diapers used

Number of diapers used will be measured using 3-day bladder diary

Time frame
12 weeks
4

Quality of Life Assessment in Spina Bifida Score

Quality of life (QoL) is measured by QUALAS assessment tool. QUALAS stands for Quality of Life Assessment of spina bifida. There are separate (but largely similar) versions for adults (QUALAS-A), children aged 8-12 (QUALAS-C) and teenagers (QUALAS-T). Each of these have further "domains" (that are scored from 0-100) that are aggregated to report quality of life scores (see below): 2 domains each for QUALAS C and T, and 3 domains for QUALAS-A. Lower scores in C and T indicate better QoL. But in QUALAS A it is mixed (Domain 1 -'Health and Relationships' : Higher scores indicate better QoL; Domain 2- 'Esteem and Sexuality' : Lower scores indicate better QoL ; Domain 3- 'Bowel and Bladder' : Lower scores indicate better QoL)

Time frame
12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.